INS and metabolic syndrome: A study on type 2 diabetic high-fat-fed rats by Sahin et al. (2013) showed that Cr(III) could prevent pathological alterations in the liver, kidneys, and pancreas due to its anti-dyslipidemia and antioxidant, insulin-sensitizing, and anti-inflammatory activities [58].